Mechanism: Understanding why it happens could lead to prevention strategies or adjunct treatments that allow higher doses without dysesthesia
Glucagon-like peptide-1 receptor agonists have demonstrated significant weight loss and cardiovascular benefits in both patients with and without diabetes, including a reduction in major adverse cardiovascular events
The nutritional concerns are the same across all GLP-1 receptor agonists because the underlying mechanism , reduced food intake , is shared
By administering insulin, we help our patients maintain optimal blood sugar levels, thereby reducing the risk of complications associated with diabetes
Can Mounjaro affect your period
What to expect: Average weight loss: 1015% of body weight Clothing fits looser, energy levels rise Better sleep and mood stability Blood pressure and cholesterol may start improving Achieve tip: Pair your medication with resistance training or walking